"[What] I often tell people is not 'should drug companies make a huge profit when they create a new drug'; [it] is how big that profit should be," CP3 Director Dr. Walid Gellad told the Pittsburgh Post-Gazette. “What is the right amount of return?”
"[What] I often tell people is not 'should drug companies make a huge profit when they create a new drug'; [it] is how big that profit should be," CP3 Director Dr. Walid Gellad told the Pittsburgh Post-Gazette. “What is the right amount of return?”